International Flavors & Fragrances Inc.
NYSE•IFF
CEO: Dr. Jennifer Amy Johnson Ph.D.
Sector: Basic Materials
Industry: Chemicals - Specialty
Listing Date: 1974-12-17
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in the United States, Europe, and internationally. It operates through four segments: Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds used in savory products; beverages; sweets; and dairy products. It also provides value-added spices and seasoning ingredients; savory solutions, including spices, sauces, marinades, and mixtures; and natural antioxidants and anti-microbials. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients for food and non-food applications. Its Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that include natural flavor extracts, specialty botanical extracts, distillates, essential oils, citrus products, aroma chemicals, natural gums, and resins; and cosmetic active ingredients consisting of active and functional ingredients, and delivery systems for cosmetic and personal care product industries. Its Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
Contact Information
Market Cap
$17.95B
P/E (TTM)
-51.6
28.5
Dividend Yield
2.3%
52W High
$84.45
52W Low
$59.14
52W Range
Rank47Top 61.9%
3.4
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 3.4 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$2.59B+0.00%
4-Quarter Trend
EPS
$0.07+0.00%
4-Quarter Trend
FCF
$132.00M+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Comparable Sales Growth Achieved Net sales increased 2% on a comparable currency neutral basis in 2025 versus 2024, despite reported sales decline of 5% to $10.890B.
Gross Margin Expansion Gross margin reached 36.2% in 2025, improving 30 basis points compared to 35.9% reported in 2024.
Segment Performance Strength Taste and Food Ingredients segments showed strong comparable currency neutral Adjusted EBITDA growth of 10% each in 2025.
Major Divestiture Activity Completed divestitures of Pharma Solutions and Nitrocellulose groups in 2025, streamlining core business focus.
Risk Factors
Significant Goodwill Impairment Recorded $1.153B goodwill impairment charge in 2025, primarily impacting the Food Ingredients reporting unit.
Operating Profit Deterioration Reported operating loss of $(382)M in 2025, contrasting sharply with $766M profit achieved in 2024.
Input Cost Inflation Pressure Increases in raw material, transportation, and energy costs exacerbated by inflation pressure profitability outlook.
Competitive Market Dynamics Intense global competition and customer reliance on "core lists" may adversely affect sales and margin realization.
Outlook
Strategic Segment Realignment Completed restructuring Nourish segment into Taste and Food Ingredients effective January 1, 2025 for better focus.
Share Repurchase Authorization Board authorized new $500M share repurchase program commencing October 1, 2025, supporting capital allocation goals.
Productivity Program Timeline IFF Productivity Program initiatives are targeted for substantial completion by December 31, 2026 to enhance efficiency.
2026 Capital Spending Guidance Expect capital spending in 2026 to be approximately 6% of sales, reflecting prioritized project evaluation.
Peer Comparison
Revenue (TTM)
$48.69B
$39.97B
$30.15B
Gross Margin (Latest Quarter)
47.2%
41.1%
40.8%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| DOW | $25.83B | -9.9 | -15.5% | 33.5% |
| PPG | $23.12B | 14.7 | 33.6% | 93.6% |
| LYB | $22.90B | -30.8 | -6.6% | 46.9% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-3.1%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow
Deep Research
Next earnings:May 4, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data